Actinium Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 224.5 | 180.0 | 171.0 | 113.0 | 77.2 | 91.8 | 176.8 | 240.1 | 1,196.7 | 1,220.2 | 1,400.4 | 1,739.9 | 2,685.3 | 2,750.2 | 728.8 | 50.1 | 61.6 | 53.9 | 55.5 | 485.3 | 347.1 | 0.9 | |
| 4.7 | 2.7 | 6.5 | 7.9 | 2.3 | 4.3 | 1.5 | 4.1 | 7.1 | 5.2 | 10.5 | 2.4 | 3.8 | 6.7 | 10.9 | 2.4 | 3.3 | 2.3 | 2.0 | 2.0 | 2.4 | 1.8 | 1.6 | 1.5 | 2.6 | 4.1 | 4.3 | 3.7 | 3.7 | 3.9 | 5.0 | 5.1 | 1.5 | 1.2 | 1.9 | 2.3 | 3.6 | 5.6 | 13.6 | 1.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 109.1 | 88.2 | 98.2 | 45.2 | 28.1 | -1.7 | 71.0 | 145.4 | 735.8 | 649.4 | 677.1 | 800.0 | 1,654.4 | 1,694.8 | -235.4 | -39.2 | -18.3 | -19.3 | -3.2 | -40.0 | -112.9 | -0.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.2 | 16.9 | 33.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -30.9% | -42.4% | -25.6% | -32.0% | -53.9% | -37.0% | -66.2% | -26.5% | -23.9% | -45.2% | -36.9% | -57.7% | -55.4% | -56.6% | -66.1% | -17.6% | -13.6% | -15.3% | -15.5% | -13.6% | -11.7% | -16.2% | -18.7% | 9.8% | 5.9% | 3.0% | -0.4% | -21.9% | -29.9% | -33.7% | -18.3% | -15.3% | -59.0% | -81.6% | -66.7% | -70.3% | -50.2% | -56.5% | -73.6% | -75.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 88.0% | 81.3% | 63.4% | 35.9% | 28.9% | -320.6% | -457.9% | -659.6% | -875.3% | -917.3% | -892.6% | -895.1% | -100.1% | -98.8% | -100.6% | -58.1% | 328.9% | 312.2% | 101.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,550.2% | -2,533.2% | -2,083.1% | -2,182.2% | -1,693.3% | -2,218.5% | -2,930.8% | -2,981.1% | -19,864.7% | -30,387.4% | -46,375.4% | -64,098.8% | -61,645.7% | -57,665.4% | -55,504.9% | -5,200.1% | -6,069.4% | -5,462.6% | -4,148.7% | -40,274.4% | -28,346.7% | 27.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,515.3% | -2,506.9% | -2,064.6% | -2,165.6% | -1,681.5% | -2,202.2% | -2,885.1% | -2,886.1% | -19,080.9% | -29,144.0% | -43,983.3% | -60,269.1% | -57,346.9% | -52,621.0% | -50,512.3% | -4,721.4% | -5,618.6% | -5,066.2% | -3,844.3% | -37,652.2% | -26,078.9% | 32.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,482.6% | -2,454.5% | -2,002.7% | -1,835.6% | -1,446.0% | 898.6% | 1,046.5% | 723.6% | -532.8% | -26,682.4% | -41,922.8% | -58,627.2% | -49,037.0% | -41,977.8% | -42,990.1% | -4,084.3% | -4,107.7% | -3,789.1% | -2,782.4% | -27,426.7% | -25,535.6% | -66.2% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -169.8% | -135.1% | -217.3% | -320.3% | -154.7% | -194.6% | -114.3% | -130.9% | -194.2% | -268.3% | -430.5% | -147.5% | -237.7% | -388.0% | -725.1% | -42.3% | -45.0% | -36.2% | -30.9% | -27.7% | -28.8% | -33.7% | -35.7% | -35.0% | -42.6% | -49.7% | -68.0% | -87.3% | -115.0% | -134.2% | -105.9% | -97.2% | -107.1% | -116.7% | -177.1% | -215.8% | -251.0% | -432.6% | -1,018.7% | 37.3% | |
| -140.0% | -108.0% | -153.4% | -218.9% | -129.5% | -145.1% | -88.3% | -100.3% | -143.2% | -158.8% | -188.0% | -106.2% | -144.7% | -187.6% | -261.8% | -38.4% | -40.4% | -33.5% | -29.1% | -26.4% | -27.4% | -30.8% | -33.0% | -22.4% | -26.0% | -28.9% | -38.2% | -46.8% | -56.4% | -59.9% | -52.6% | -47.4% | -49.8% | -49.7% | -66.3% | -65.1% | -61.6% | -65.5% | -51.7% | 28.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -15 | -20 | -17 | -11 | -20 | -17 | -27 | – | – | -13 | -8.6 | -19 | -14 | -8.9 | -5.3 | -53 | -48 | -63 | -72 | -82 | -82 | -78 | -72 | -116 | -111 | -108 | -94 | -91 | -82 | -76 | -84 | -85 | -78 | -72 | -65 | -59 | -53 | -47 | -41 | -36 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.9 | |
| 82.5% | 79.9% | 70.6% | 68.4% | 83.8% | 74.6% | 77.3% | 76.7% | 73.7% | 59.2% | 43.7% | 72.0% | 60.9% | 48.4% | 36.1% | 90.7% | 89.9% | 92.4% | 94.2% | 95.3% | 95.0% | 91.5% | 92.3% | 64.2% | 61.0% | 58.2% | 56.1% | 53.6% | 49.0% | 44.7% | 49.6% | 48.8% | 46.5% | 42.6% | 37.4% | 30.2% | 24.5% | 15.1% | 5.1% | 75.5% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.3 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -15.22 | -13.06 | -15.02 | -14.65 | -11.64 | -9.02 | -8.43 | -6.16 | -6.11 | -6.05 | -5.89 | -4.58 | -4.34 | -3.80 | -3.78 | -1.89 | -1.32 | -1.21 | -1.19 | -1.10 | -1.07 | -1.15 | -1.11 | -1.15 | -1.21 | -1.29 | -1.51 | -1.77 | -1.85 | -1.77 | -1.67 | -1.42 | -1.32 | -1.23 | -1.46 | -1.32 | -1.11 | -1.09 | -0.75 | 0.36 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.04 | 0.05 | 0.05 | 0.07 | 0.05 | 0.04 | 0.04 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 1.12 | |
| 8.96 | 9.67 | 6.91 | 4.57 | 7.52 | 4.64 | 7.38 | 4.71 | 3.15 | 2.26 | 1.37 | 3.11 | 1.82 | 0.98 | 0.52 | 4.46 | 2.94 | 3.34 | 3.85 | 3.98 | 3.73 | 3.41 | 3.11 | 3.29 | 2.83 | 2.59 | 2.23 | 2.02 | 1.61 | 1.32 | 1.57 | 1.46 | 1.23 | 1.05 | 0.82 | 0.61 | 0.44 | 0.25 | 0.07 | 0.96 | |
| -12.96 | -11.19 | -11.51 | -11.53 | -9.37 | -7.32 | -7.35 | -5.09 | -5.31 | -5.29 | -5.31 | -4.33 | -3.82 | -3.73 | -3.77 | -1.84 | -1.32 | -1.19 | -1.18 | -1.08 | -1.04 | -0.97 | -0.95 | 0.47 | 0.44 | 0.32 | -0.04 | -1.62 | -1.77 | -1.72 | -1.42 | -1.13 | -1.12 | -1.06 | -1.07 | -0.98 | -0.80 | -0.79 | -0.74 | -0.74 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.